Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

Clinical trial NCT04416633 · COMPLETED

Trial details

NCT number: NCT04416633
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Unresectable Non-small Cell Lung Cancer (NSCLC)

Start date: 2021-11-30
Primary completion: 2023-10-27
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.